Ollin Biosciences to Attend Investor Conferences

The biotech firm will present at two upcoming events to discuss its latest developments.

Apr. 8, 2026 at 1:42pm

Got story updates? Submit your updates here. ›

Ollin Biosciences, a biotechnology company based in Austin, Texas, has announced that it will participate in two upcoming investor conferences in the coming weeks. The company plans to provide updates on its latest research and development initiatives at these events.

Why it matters

Investor conferences are an important platform for publicly-traded biotech firms like Ollin to engage with the financial community, showcase their progress, and potentially attract new investors to support their growth.

The details

Ollin Biosciences will present at the 34th Annual Roth Conference on April 16th and the 28th Annual Needham Virtual Growth Conference on April 18th. The company's management team will discuss Ollin's pipeline of drug candidates and provide an overview of its business strategy and milestones.

  • Ollin Biosciences will present at the 34th Annual Roth Conference on April 16, 2026.
  • Ollin Biosciences will present at the 28th Annual Needham Virtual Growth Conference on April 18, 2026.

The players

Ollin Biosciences

A biotechnology company based in Austin, Texas that is developing a pipeline of drug candidates.

Got photos? Submit your photos here. ›

The takeaway

Ollin Biosciences' participation in these high-profile investor conferences signals its commitment to transparency and engagement with the financial community as it continues to advance its drug development programs.